000 01552 a2200397 4500
005 20250516050518.0
264 0 _c20111019
008 201110s 0 0 eng d
022 _a1550-6606
024 7 _a10.4049/jimmunol.1101268
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorbulevych, Oleg Y
245 0 0 _aTCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cSep 2011
300 _a2453-63 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAnimals
650 0 4 _aCross Reactions
650 0 4 _aCrystallography, X-Ray
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aHLA-A2 Antigen
_xchemistry
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMART-1 Antigen
_xchemistry
650 0 4 _aNeoplasms
_ximmunology
650 0 4 _aProtein Binding
650 0 4 _aProtein Structure, Quaternary
650 0 4 _aProtein Structure, Secondary
650 0 4 _aReceptors, Antigen, T-Cell
_xchemistry
650 0 4 _aT-Lymphocytes
_xchemistry
700 1 _aSanthanagopolan, Sujatha M
700 1 _aHossain, Moushumi
700 1 _aBaker, Brian M
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 187
_gno. 5
_gp. 2453-63
856 4 0 _uhttps://doi.org/10.4049/jimmunol.1101268
_zAvailable from publisher's website
999 _c21041657
_d21041657